YSC1
Yeast from Saccharomyces cerevisiae
Type I
Synonym(s):
(Bakers yeast)
Sign In to View Organizational & Contract Pricing.
Select a Size
About This Item
NACRES:
NA.81
UNSPSC Code:
12352202
Product Name
Yeast from Saccharomyces cerevisiae, Type I
biological source
Saccharomyces cerevisiae
type
Type I
form
powder or solid
application(s)
food and beverages
microbiology
storage temp.
2-8°C
Quality Level
Application
Yeast from Saccharomyces cerevisiae has been used:
- as a biocatalyst for the anode of yeast microbial fuel cell
- for the production of ethanol for fuel use
- to prepare yeast extract
Biochem/physiol Actions
Yeast from Saccharomyces cerevisiae (Baker′s yeast) is used as a protein supplement, energy booster and immune enhancer. It serves as a dough leavening agent in bread production by converting the fermentable sugars to CO2 and ethanol. Baker′s yeast exhibits aroma, anti-molding and nutritive properties. It acts as a cell factory.
Disclaimer
Autolyzes in aqueous buffer at 37 °C.
General description
Yeast from Saccharomyces cerevisiae (Baker′s yeast) is the oldest microbial starter. It is a facultative anaerobe.
Preparation Note
Dried to avoid inactivation of enzymes.
Storage Class
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Enhanced ethanol production via electrostatically accelerated fermentation of glucose using Saccharomyces cerevisiae
Mathew AS, et al.
Scientific Reports, 5, 15713-15713 (2015)
Rebeccah J Katzenberger et al.
G3 (Bethesda, Md.), 6(12), 4151-4166 (2016-10-19)
Outcomes of traumatic brain injury (TBI) vary because of differences in primary and secondary injuries. Primary injuries occur at the time of a traumatic event, whereas secondary injuries occur later as a result of cellular and molecular events activated in
A microbial biofuel cell with an air-breathing cathode for in vivo glucose sensing applications
Lee JW
Analytical Methods : Advancing Methods and Applications, 7(8), 3324-3326 (2015)
Engineering baker?s yeast: room for improvement
Randez-Gil F, et al.
Trends in biotechnology, 17(6), 237-244 (1999)
Zachariah P G Olufs et al.
Scientific reports, 8(1), 2348-2348 (2018-02-07)
Genetic variability affects the response to numerous xenobiotics but its role in the clinically-observed irregular responses to general anesthetics remains uncertain. To investigate the pharmacogenetics of volatile general anesthetics (VGAs), we developed a Serial Anesthesia Array apparatus to expose multiple
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service